Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine for recovery quality after gynecologic laparoscopic surgery
ChiCTR2400094452Phase 4Not yet recruiting
- Sponsor
- First People's Hospital of Zunyi
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine in Fibromyoma (LM), Cervical Cancer (CC), endometrial cancer (EC) and 1 more (2 arms), sponsored by First People's Hospital of Zunyi. Primary endpoint: Postoperative recovery quality. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
Fibromyoma (LM)Cervical Cancer (CC)endometrial cancer (EC)ovarian cancer
Beyond the preview
Go deeper on ChiCTR2400094452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400094452.